Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors
Clinical trial NCT05423977 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05423977
- Sponsor
- Hangzhou Adcoris Biopharmacy Co., Ltd
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2023-05-05
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.